...
首页> 外文期刊>ChemMedChem >Multitarget Drugs: Synthesis and Preliminary Pharmacological Characterization of Zileuton Analogues Endowed with Dual 5-LO Inhibitor and NO-Dependent Activities
【24h】

Multitarget Drugs: Synthesis and Preliminary Pharmacological Characterization of Zileuton Analogues Endowed with Dual 5-LO Inhibitor and NO-Dependent Activities

机译:多靶点药物:具有双重5-LO抑制剂和NO依赖活性的齐留通类似物的合成和初步药理学表征

获取原文
获取原文并翻译 | 示例
           

摘要

The leukotrienes (LTs) are a family of lipid-derived autacoids that originate from arachidonic acid (AA). 5-Lipooxygenase (5-LO) is the key enzyme in this process. It transforms AA through a two-step process, first into 5-hydroperoxyeicosatetraenoic acid (5-HPETE), and then into unstable leukotriene A4 (LTA4). This intermediate can be transformed either by leukotriene B4 synthase into leukotriene B4 (LTB4), or by leukotriene C4 synthase, which is a specific glutathione transferase, into peptide-lipid leukotrienes C4, D4, and E4 (LTC4, LTD4, LTE4).
机译:白三烯(LTs)是源自花生四烯酸(AA)的脂质衍生的类胡萝卜素家族。 5-Lipooxygenase(5-LO)是此过程中的关键酶。它通过两步过程将AA转化为5-氢过氧二十碳四烯酸(5-HPETE),然后转化为不稳定的白三烯A4(LTA4)。该中间体可以通过白三烯B4合酶转化为白三烯B4(LTB4),或通过白三烯C4合酶(一种特定的谷胱甘肽转移酶)转化为肽-脂质白三烯C4,D4和E4(LTC4,LTD4,LTE4)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号